Chemoinformaics analysis of Malvidin-3-O-(6-p-coumaroyl)glucoside
| Molecular Weight | 639.586 | nRot | 9 |
| Heavy Atom Molecular Weight | 608.338 | nRig | 31 |
| Exact Molecular Weight | 639.171 | nRing | 5 |
| Solubility: LogS | -3.591 | nHRing | 2 |
| Solubility: LogP | 3.085 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 3 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 22 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 23 |
| nHA | 13 | APOL | 85.3386 |
| nHD | 7 | BPOL | 42.3834 |
| QED | 0.08 |
| Synth | 4.451 |
| Natural Product Likeliness | 1.573 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.025 |
| Pgp-sub | 0.983 |
| HIA | 0.806 |
| CACO-2 | -6.372 |
| MDCK | 0.0000125 |
| BBB | 0.029 |
| PPB | 0.939878 |
| VDSS | 0.599 |
| FU | 0.129241 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.041 |
| CYP2c9-sub | 0.722 |
| CYP2d6-inh | 0.13 |
| CYP2d6-sub | 0.298 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.063 |
| CL | 8.289 |
| T12 | 0.89 |
| hERG | 0.081 |
| Ames | 0.677 |
| ROA | 0.059 |
| SkinSen | 0.702 |
| Carcinogencity | 0.118 |
| EI | 0.019 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.878 |
| Antiviral | Yes |
| Prediction | 0.85621 |